DxVx plans to make a license-in agreement of OVM-200
Final stage in licensing OVM-200 from Oxford Vacmedix in the UK
Final stage in licensing OVM-200 from Oxford Vacmedix in the UK
Pitavastatin Tablets are indicated as an adjunct to diet to reduce low-density lipoprotein cholesterol
Azelis will be the exclusive distributor for inulin, oligofructose, scFOS, texturized wheat proteins, faba beans, Beta-glucans, meatless solution
Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution
LG Chem is making progress in the development of the world's first oral treatment for rare forms of obesity.
Multi-million dollar investment augments in-vitro biology capabilities in primary and secondary screening
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
The companies will spread the adoption of the latest HOS and Mass Spec technologies to help scientists improve the safety, stability, and effectiveness of biotherapeutics
Subscribe To Our Newsletter & Stay Updated